Please select the option that best describes you:
Topics:
Radiation Oncology • Neuro-Oncology
How do you approach SRS for brain metastases in the setting of a connective tissue disorder such as lupus or scleroderma?
Do you make any modifications to your dose or treatment technique?
Answer from: Radiation Oncologist at Academic Institution
Historically, connective tissue disorders (CTD) have been considered to be a relative contraindication to radiotherapy generally - due to concerns of potential increased risk of complications. Data on this issue is somewhat conflicting. In the setting of SRS for brain metastases or brain tumors, the...
Sign in or Register to read more